Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts
Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts
GlobeNewswire –

Press release – No. 19 / 2026 Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts Builds on the Metabolic Frontier 2030 strategy, advancing its ambition to become a leader in obesity and metabolic health…

cnbc.com - Joshua Brown - There's one pharma-linked stock most investors have never heard of. It's on Josh Brown's list
There's one pharma-linked stock most investors have never heard of. It's on Josh Brown's list
CNBC –

(This is The Best Stocks in the Market, brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh — There's a good chance you've never heard of West Pharmaceutical Services (WST). There's an even better chance you've…

globenewswire.com - Amplio Pharma - Amplio Pharma Reports Positive Early Clinical Results for NovoBioJect, Designed to Make the World's Most-Used Rheumatoid Arthritis Drug Work for More Patients
Amplio Pharma Reports Positive Early Clinical Results for NovoBioJect, Designed to Make the World's Most-Used Rheumatoid Arthritis Drug Work for More Patients
GlobeNewswire –

A single dose of NovoBioJect increased the active form of methotrexate inside patients' immune cells by 38%, a first step toward a potential next-generation first-line treatment for rheumatoid arthritis First clinical proof of principle. In an…

fool.com - Thomas Niel - Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy?
Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy?
The Motley Fool –

Whether it's biotech stocks or regular pharmaceutical stocks, when investors buy a particular name in healthcare, they are making a wager on a single company's pipeline. However, there is one unique name within this space that enables investors to…

newswire.ca - Corporation JAMP Pharma - Orimed Pharma launches PrBALANSYA, Canada's only escitalopram oral solution
Orimed Pharma launches PrBALANSYA, Canada's only escitalopram oral solution
CNW –

Orimed Pharma, part of the JAMP Pharma Group, launches BALANSYA, the only escitalopram oral solution available in Canada. The 2 mg/mL formulation gives healthcare professionals an oral liquid option when prescribing escitalopram. Following the…

axios.com - Caitlin Owens - China eyes competition with Big Pharma over next 5 years
China eyes competition with Big Pharma over next 5 years
Axios –

China is making it clear that it wants to become a powerhouse on a par with large Western pharmaceutical companies in the near future, and not just strike licensing deals for promising new drug candidates. Why it matters: Some experts warn that big…

marketbeat.com - Avalyn Pharma Inc. (NASDAQ:AVLN) Stock Now Rated 'Moderate Buy' by Wall Street Analysts
Avalyn Pharma Inc. (NASDAQ:AVLN) Stock Now Rated 'Moderate Buy' by Wall Street Analysts
MarketBeat –

Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) has earned a consensus recommendation of 'Moderate Buy' from the six research firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock…

globenewswire.com - Nxera Pharma - Nxera Announces Successful Resolution of miniG Patent Infringement Action
Nxera Announces Successful Resolution of miniG Patent Infringement Action
GlobeNewswire –

Tokyo, Japan and Cambridge and London, UK, 30 September 2026 – Nxera Pharma Co., Ltd. (“Nxera Pharma” or “the Company”; TSE 4565) announces that its wholly owned subsidiary Nxera Pharma UK Limited…

fool.com - Adria Cimino - Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.
Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.
The Motley Fool –

If you've been looking for high-yield stocks, Pfizer (PFE -1.40%) may have crossed your radar screen. As shares of the pharma giant slipped over the past few years, its dividend yield marched higher, and in recent times, settled at 6%. High…

thehindu.com - The Hindu Bureau - Aurobindo arm Acrotech Biopharma forays into U.S. dermatology market with atopic dermatitis ointment
Aurobindo arm Acrotech Biopharma forays into U.S. dermatology market with atopic dermatitis ointment
The Hindu –

Aurobindo Pharma subsidiary Acrotech Biopharma has launched Adquey (difamilast 1%) ointment, a non-steroidal topical treatment for mild-to-moderate atopic dermatitis, in the U.S. The product will compete in a market estimated to be around $1.3…

gizmodo.com - Bruce Gil - Gavin Newsom Signs Bill Banning 'Robo Bosses' as Part of California Crackdown on AI
Gavin Newsom Signs Bill Banning 'Robo Bosses' as Part of California Crackdown on AI
Gizmodo | The Future Is Here –

A day after President Donald Trump had lunch with some of the nation's top AI executives, California Gov. Gavin Newsom signed a slate of bills Wednesday aimed at putting new guardrails on the technology. Chief among them was the “ No Robo…

seekingalpha.com - High Alpha Professor - TPG: Weak Realizations Are Hiding A Much Stronger Fee Business (NASDAQ:TPG)
TPG: Weak Realizations Are Hiding A Much Stronger Fee Business (NASDAQ:TPG)
Seeking Alpha –

TPG Inc. is rated Buy with a $55 price target, despite a sharp decline from its 52-week high. TPG's fee-related earnings surged 43% and fee-earning AUM rose 24%, while weak realizations drove the stock lower. Approximately $51.7 billion of AUM is…

newswire.ca - VALITIC™ Featured by BuzzFeed for 'Magical Results,' Further Strengthening Consumer Brand Momentum
VALITIC™ Featured by BuzzFeed for 'Magical Results,' Further Strengthening Consumer Brand Momentum
CNW –

BuzzFeed Feature Expands VALITIC™'s Reach to BuzzFeed's Significantly Larger Consumer Audience HERZLIYA, Israel and CALGARY, Alberta, Oct. 1, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ('Innocan' or the 'Company')…

fastcompany.com - Joe Berkowitz - RFK's MAHA Summit proves MAHA truly is just MAGA for your health
RFK's MAHA Summit proves MAHA truly is just MAGA for your health
Fast Company –

Nearly two years into his current position as secretary of health and human services, Robert F. Kennedy Jr.'s unlikely ascendance still seems like a paradox—or at least a dark joke. Somehow, a person best known for being one of the world's…

heraldscotland.com - Agnes Stevenson - The Scottish Impact Awards - full list of winners revealed
The Scottish Impact Awards - full list of winners revealed
The Herald –

Through regular wellbeing conversations, training for managers and by establishing a network of Mental Health First Aiders, he has banished stigma and created a supportive environment, dramatically reducing stress-related absences within the…

Receive a Daily briefing on Pharma Industry News

Get Started